Albion Enterprise VCT PLC
Albion Development VCT has now merged into Albion Enterprise VCT. To access all the details click below
Albion Enterprise VCT PLC's financial year ends 31 March
Key Highlights
Dividends paid and recently
declared since launch:
97.98p
NAV* at 31 March 2025:
Ordinary shares
113.31p
Total Return:
Ordinary shares
211.29p
Next dividend due to shareholders
29/08/2025
2.91p
*Where applicable, Net Asset Value is reduced by dividend declared.
The London Stock Exchange code for the VCT is AAEV
Performance Data
The diagram above shows the one year, three year, five year and ten year total return to shareholders. This return comprises dividends paid and the change in net asset value over the relevant periods to 31 March 2025.
Net asset value per share and total shareholder value
The chart above illustrates the movement in net asset value per share plus cumulative dividends paid in the past ten years to 31 March 2025.
Percentage movement in shareholder value in the year
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 12.7% | 20.7% | 2.1% | 2.7% | 8.2% |
The figures in the table above represent the percentage movement in shareholder value on opening NAV over the past five years. The Company has delivered an average increase in shareholder value on opening NAV of 9.3% per annum over the past five years.
Financials
Annual Report
AGM
The next AGM is scheduled for 10 September 2025.
It will be held virtually at 12PM. Access using link below.
2024 AGM recording
Manager Presentation
Board of Directors
Ben Larkin
Chairman
Ben Larkin
Chairman
Chair, Independent Non-Executive Director, LLB
appointed 19 December 2024
Key relevant skills:
• Leadership skills
• Business reorganisation skills
• Corporate governance
Ben is a partner at an international law firm, Jones Day. He heads up the business reorganisation practice across Europe. He has spent the majority of his career advising public and private boards on aspects of corporate governance and has particular expertise in the infrastructure and real estate sectors. Recent mandates include Openfiber (the Italian nationwide fiber network), Southern Water and HES. Prior to joining Jones Day, he led the business recovery and reconstruction division of Berwin Leighton Paisner LLP for 14 years.
Christopher Burrows
Director
Christopher Burrows
Director
Independent Non-Executive Director, MA
appointed 27 June 2018
Key relevant skills:
• Extensive strategy experience in healthcare
• Leadership consulting
• Organisation strategy
Christopher gained 35 years experience in international leadership consulting, executive search and assessment. Having graduated in Anthropology from the University of Cambridge, he started his consulting career with Whitehead Mann and subsequently became the youngest partner at Goddard Kay Rogers. He retired from Russell Reynolds Associates in 2018, having been a managing director for the last 13 years of his executive career there. His principal focus was advising clients & investors on board appointments and organisation strategy across biotechnology, MedTech, diagnostics, healthcare services, pharmaceuticals and digital technologies.
James O’Shaughnessy
Director
James O’Shaughnessy
Director
Independent Non-Executive Director, MA (Oxon)
appointed 19 December 2024
Key relevant skills:
• Extensive background in life-sciences and healthcare
• Previous Director of Policy at 10 Downing Street
• Organisation strategy
Lord James O’Shaughnessy has operated at the highest levels across UK Government, including as a Parliamentary Under Secretary in the Department for Health & Social Care with key policy responsibilities including life sciences; medicines pricing and regulation; preparing the health and social care sectors for Brexit; and, data, digital and technology, including cyber security. He was created a life peer in 2015 taking the title Baron O’Shaughnessy, of Maidenhead in the Royal County of Berkshire, and previously served as Director of Policy in No.10 Downing Street. He is a senior partner at Newmarket Strategy, a healthcare and life sciences consultancy, and a Trustee at Health Data Research UK.
Philippa Latham
Director
Philippa Latham
Director
Independent Non-Executive Director, MA, MBA, ACIS
appointed 1 September 2021
Key relevant skills:
• Corporate financier
• Corporate analyst
• Audit & Risk Committee experience
After graduating in Economics at Cambridge, Philippa started her career in corporate finance in the City and has experience in industry as a financial analyst, FCMA accountant and as a quoted company secretary. She was a non-executive director from 2005 to 2015 at James Latham PLC, an AIM listed company, where she served as the chair of the Audit Committee for seven years. She currently holds four non-executive director roles, one of which is Lucy Group Limited where she is chair of the Audit Committee.
Rhodri Whitlock
Director
Rhodri Whitlock
Director
Chairman of the Audit and Risk Committee, Independent Non-Executive Director
appointed 19 January 2021
Key relevant skills:
• Chartered accountant
• Corporate governance
• Financial Reporting
• Valuations
• Experience listed and private company auditor
• Member of the ICAEW’s Audit and Assurance Faculty Board
• Member of ICAS’ Corporate & Financial Reporting Panel
• Former member of the AIC VCT Technical Subcommittee
Rhodri is a chartered accountant and has over 25 years’ experience as a partner providing a range of assurance services and advice to listed and private companies. During that time Rhodri worked closely with the non-executive boards of a significant number of investment and infrastructure funds and also gained considerable experience of high growth businesses and sectors including MedTech, FinTech, software as a service, healthcare and e-commerce. Rhodri served on the AIC’s VCT technical sub-committee for approximately 7 years. More recently, Rhodri worked with the independent regulator, the Financial Reporting Council and now runs his own consultancy business, HPL Associates Limited and AQRA Limited. He is also a member of the ICAEW’s Audit and Assurance Board. Outside of his professional work, Rhodri is a guest lecturer at the University of Portsmouth, supporting the academic team with undergraduate and postgraduate programmes.
Portfolio highlights
Quantexa
Software
Proveca
Healthcare
Oviva
Healthcare
Elliptic
Software
Runa
Software
Phasecraft
DeepTech
Treefera
Software
Chonais River Hydro Ltd
Infrastructure
Dividends
We operate a variable dividend policy which targets an annual dividend yield of around 5% of the prevailing net asset value, paid bi-annually.
The Albion VCTs operate Dividend Re-investment Schemes. Investors who would prefer a capital growth option can re-invest their dividends to obtain more shares in the VCTs.
Any amounts reinvested are eligible for income tax relief of 30%, subject to the investor’s tax position.
Investors wishing to take advantage of this opportunity should read the dividend reinvestment schemes T&C below.
Shareholders who are in the dividend reinvestment scheme but want to receive dividend as cash can amend their income option via Investor Centre.
Shareholders can also amend their income option by completing a Payment of Interest form, found below, and send directly to Computershare.
If the shareholder choses to amend their income option via the Payment of Interest form, Computershare will also require a written confirmation from the shareholder to be fully removed from the scheme.
Corporate Governance
Inside Information Announcements
14 March 2025 16:00 – NAV announcement
16 August 2024 13:30 – NAV Update
24 July 2024 13:04 – Merger Discussions
12 March 2024 15:30 – Portfolio and NAV Update
02 March 2023 18:00 – Portfolio and NAV Update
03 August 2021 11:00 – NAV Update
21 June 2021 12:15 – Portfolio and NAV Update
Nomination Committee Terms of Reference
Remuneration Committee Terms of Reference
Audit and Risk Committee terms of reference
Other
Report Archive
Additional Information
Dividend Reinvestment Scheme
Shareholders who want to receive dividend as cash and decide not to amend their income option via Investor Centre (the online portal) must complete a payment of interest form and send directly to Computershare.
If the shareholder is in the dividend reinvestment scheme, Computershare will also require a written confirmation from the shareholder to be fully removed from the scheme.
Contact
Computershare Investor Services PLC can be contacted at their Investor Centre on +44 (0)370 873 5860 (Calls are charged at no more than your current providers national call rate and calls may be recorded. Lines are open Monday – Friday, 8:30am – 5:30pm).
Alternatively you can visit their website www.computershare.com/uk.
